Your browser doesn't support javascript.
loading
Efficacy and safety of abiraterone acetate plus prednisolone in patients with early metastatic castration-resistant prostate cancer who failed first-line androgen-deprivation therapy: a single-arm, phase 4 study.
Kobayashi, K; Okuno, N; Arai, G; Nakatsu, H; Maniwa, A; Kamiya, N; Satoh, T; Kikukawa, H; Nasu, Y; Uemura, H; Nakashima, T; Mikami, K; Iinuma, M; Tanabe, K; Furukawa, J; Kobayashi, H.
Affiliation
  • Kobayashi K; Department of Urology, Federation of National Public Service Personnel Mutual Aid Associations Yokosuka Kyosai Hospital, Kanagawa, Japan.
  • Okuno N; Department of Urology, Independent Administrative Institution National Hospital Organization Sagamihara Hospital, Kanagawa, Japan.
  • Arai G; Department of Urology, Dokkyo Medical University Saitama Medical Center, Saitama, Japan.
  • Nakatsu H; Department of Urology, Asahi General Hospital, Chiba, Japan.
  • Maniwa A; Department of Urology, Independent Administrative Institution National Hospital Organization Shizuoka Medical Center, Shizuoka, Japan.
  • Kamiya N; Department of Urology, Toho University Sakura Medical Center, Chiba, Japan.
  • Satoh T; Department of Urology, Kitasato University School of Medicine, Kanagawa, Japan.
  • Kikukawa H; Department of Urology, Independent Administrative Institution National Hospital Organization Kumamoto Medical Center, Kumamoto, Japan.
  • Nasu Y; Department of Urology, Japan Organization of Occupational Health and Safety Okayama Rosai Hospital, Okayama, Japan.
  • Uemura H; Department of Urology and Renal Transplantation, Yokohama City University Medical Center, Kanagawa, Japan.
  • Nakashima T; Department of Urology, Ishikawa Prefectural Central Hospital, Ishikawa, Japan.
  • Mikami K; Department of Urology, Chibaken Saiseikai Narashino Hospital, Chiba, Japan.
  • Iinuma M; Department of Urology, Independent Administrative Institution National Hospital Organization Mito Medical Center, Ibaraki, Japan.
  • Tanabe K; Department of Urology, Tokyo Women's Medical University Hospital, Tokyo, Japan.
  • Furukawa J; Department of Urology, National University Corporation Kobe University Hospital, Hyogo, Japan.
  • Kobayashi H; Janssen Pharmaceutical K.K., Tokyo, Japan.
Jpn J Clin Oncol ; 51(4): 544-551, 2021 Apr 01.
Article in En | MEDLINE | ID: mdl-33324967
Subject(s)
Key words
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisolone / Antineoplastic Combined Chemotherapy Protocols / Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate / Androgens Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom
Fulltext
Add to My VHL
Print
XML
PubMed Links
Search on Google

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Prednisolone / Antineoplastic Combined Chemotherapy Protocols / Prostatic Neoplasms, Castration-Resistant / Abiraterone Acetate / Androgens Limits: Aged / Aged80 / Humans / Male / Middle aged Language: En Journal: Jpn J Clin Oncol Year: 2021 Document type: Article Affiliation country: Japan Country of publication: United kingdom